Fulgent Genetics Stock Price and Value Analysis

Should you buy Fulgent Genetics stock? (NASDAQ:FLGT). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
None.
  • This company is not making money.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company is less known than others.
  • This company pays no dividend.

Inside the FLGT Numbers

FLGT Price
(Fulgent Genetics stock price per share)
$86.00
[?] PE Ratio versus Sector 73% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Diagnostics & Research stocks
[?] Free Cash Flow Jitter 201%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 5,668,944 shares shorted. With 17,870,107 shares available for purchase and an average trading volume over the past 10 trading days of 789,457, it would take at least 7.181 days for all of the short holders to cover their shorts.

Is Fulgent Genetics Stock on Sale?

Based on our analysis, we believe that you should not buy Fulgent Genetics right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy FLGT Stock?

Does Fulgent Genetics have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.